Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
Blood
|
November 8, 2019
Clinical utility of targeted next-generation sequencing-based screening of peripheral blood in the evaluation of cytopenias
Vignesh Shanmugam, Aric Parnes, Rajeshwari Kalyanaraman, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 22, 2021
Improving rates of venous thromboembolism prophylaxis in multiple myeloma patients on immunomodulatory drugs through a pharmacy-based system
Aric Parnes, Houry Leblebjian, Joanna Hamilton, et al.
British Journal of Haematology
|
July 19, 2011
Resveratrol ameliorates TNFα-mediated suppression of erythropoiesis in human CD34(+) cells via modulation of NF-κB signalling
Jee-Yeong Jeong, Matthew Silver, Aric Parnes, et al.
World Journal of Stem Cells
|
September 14, 2016
Therapy-related myeloid neoplasms - what have we learned so far?
Mohammad Faizan Zahid, Aric Parnes, Bipin N Savani, et al.
Blood Reviews
|
March 21, 2018
Approach to pancytopenia: Diagnostic algorithm for clinical hematologists
Jerome Gnanaraj, Aric Parnes, Charles W Francis, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 8, 2021
Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies
Aric Parnes, Johnny N Mahlangu, Steven W Pipe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 28, 2021
Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors
Christine Kempton, Peter Trask, Aric Parnes, et al.
Biorxiv : the Preprint Server for Biology
|
May 20, 2024
Origins and diversity of pan-isotype human bone marrow plasma cells
Gaspar A Pacheco, Vishal Rao, Duck Kyun Yoo, et al.
Blood
|
August 12, 2017
Pregnancy outcomes in inherited bone marrow failure syndromes
John M Gansner, Maureen M Achebe, Kathryn J Gray, et al.
Blood Advances
|
October 3, 2024
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort
Jacqueline N Poston, Cassandra Bryan, Annette von Drygalski, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
Blood
|
November 8, 2019
Clinical utility of targeted next-generation sequencing-based screening of peripheral blood in the evaluation of cytopenias
Vignesh Shanmugam, Aric Parnes, Rajeshwari Kalyanaraman, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners
|
February 22, 2021
Improving rates of venous thromboembolism prophylaxis in multiple myeloma patients on immunomodulatory drugs through a pharmacy-based system
Aric Parnes, Houry Leblebjian, Joanna Hamilton, et al.
British Journal of Haematology
|
July 19, 2011
Resveratrol ameliorates TNFα-mediated suppression of erythropoiesis in human CD34(+) cells via modulation of NF-κB signalling
Jee-Yeong Jeong, Matthew Silver, Aric Parnes, et al.
World Journal of Stem Cells
|
September 14, 2016
Therapy-related myeloid neoplasms - what have we learned so far?
Mohammad Faizan Zahid, Aric Parnes, Bipin N Savani, et al.
Blood Reviews
|
March 21, 2018
Approach to pancytopenia: Diagnostic algorithm for clinical hematologists
Jerome Gnanaraj, Aric Parnes, Charles W Francis, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
October 8, 2021
Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies
Aric Parnes, Johnny N Mahlangu, Steven W Pipe, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia
|
January 28, 2021
Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors
Christine Kempton, Peter Trask, Aric Parnes, et al.
Biorxiv : the Preprint Server for Biology
|
May 20, 2024
Origins and diversity of pan-isotype human bone marrow plasma cells
Gaspar A Pacheco, Vishal Rao, Duck Kyun Yoo, et al.
Blood
|
August 12, 2017
Pregnancy outcomes in inherited bone marrow failure syndromes
John M Gansner, Maureen M Achebe, Kathryn J Gray, et al.
Blood Advances
|
October 3, 2024
Real-world impact of emicizumab and immunosuppression on acquired hemophilia A: a multicenter US cohort
Jacqueline N Poston, Cassandra Bryan, Annette von Drygalski, et al.
Page
of 2